SCRI - Mary Crowley Cancer Research — Dallas, Texas

SCRI - Mary Crowley Cancer Research is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI - Mary Crowley Cancer Research has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer.

Sponsors: Whitehawk Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - Mary Crowley Cancer Research?

SCRI - Mary Crowley Cancer Research has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - Mary Crowley Cancer Research conducted?

SCRI - Mary Crowley Cancer Research has 1 clinical trials on record, with 1 currently active. Their work covers PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer.

Is SCRI - Mary Crowley Cancer Research accredited by Crixeo Health?

SCRI - Mary Crowley Cancer Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - Mary Crowley Cancer Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.